Non-contact biological sensors 1, 2 that detect biological information of a person by electromagnetic waves are provided in a seat 10 on which the person sits. The biological sensors 1, 2 are disposed in the seat 10 at positions away from members A1, A2, A3 (22, 32) which are the members, from among the members that constitute the seat 10, that interfere with the passage of electromagnetic waves. The biological sensors each have a first sensor 100 and a second sensor 200 that emit electromagnetic waves of different frequencies towards the person, and the first sensor 100 is disposed adjacent to the second sensor 200. Due to this configuration, it becomes easier to accurately detect biological information.

A device is disclosed comprising: an optical physiological sensor and a further measurement system. The optical physiological sensor comprises a light emitter and a light detector configured to detect the light from the light emitter after it has been attenuated by tissue comprising blood vessels. The optical physiological sensor is configured to determine the value of a physiological parameter from the detected light. The further measurement system is configured to determine when the value of the physiological parameter is likely to be reliable. The further measurement system comprises at least one measurement subsystem, each measurement subsystem employing a different measurement modality that is also different to a measurement modality used to determine the value of the physiological parameter.

A device for measuring the turbidity of cerebrospinal fluid includes, a source of a light signal comprising having one or more wavelength(s), such that at least part of the emitted light signal passes through the cerebrospinal fluid; a flow element including an inlet and an outlet, the flow element being suitable for allowing cerebrospinal fluid to flow between the inlet and the outlet; an opaque element, arranged to absorb at least part of the emitted light signal after it has passed through the cerebrospinal fluid, and to allow another part of the emitted light signal to be reflected after it has passed through the cerebrospinal fluid; and an optical detector configured to detect the light signal after it has passed through the cerebrospinal fluid.

A device for measuring the turbidity of cerebrospinal fluid includes, a source of a light signal comprising having one or more wavelength(s), such that at least part of the emitted light signal passes through the cerebrospinal fluid; a flow element including an inlet and an outlet, the flow element being suitable for allowing cerebrospinal fluid to flow between the inlet and the outlet; an opaque element, arranged to absorb at least part of the emitted light signal after it has passed through the cerebrospinal fluid, and to allow another part of the emitted light signal to be reflected after it has passed through the cerebrospinal fluid; and an optical detector configured to detect the light signal after it has passed through the cerebrospinal fluid.

The present invention relates to a non-invasive blood glucose measuring apparatus, for measuring the glucose level in an object of measurement, comprising: (a) an irradiation source, for irradiating a narrow-band wavelength light into said object of measurement containing a blood vessel; (b) an optical detector, for collecting and processing some of the light, irradiated by said irradiating source, which is back-scattered from the object of measurement, (c) sampling means, for sampling said orthogonally polarized beams, provided by said detector-amplifiers, for converting the data of said orthogonally polarized beams into digital codes; and (d) a computing unit, wherein said computing unit comprises an adaptive filter for enhancing the cardiac pulse pulsatile waveform, and wherein said computing unit computes the glucose level, in said object of measurement, by averaging of said sampled codes.

The melanin bias reducing pulse oximeter system reduces melanin interference when obtaining pulse oximetry readings for individuals with higher skin concentrations of melanin. The system incorporates optics reducing the melanin bias through hardware and software designed using extensive testing, via a proprietary testing method. The physical pulse oximeter includes different mechanical designs, for example, finger clip, ring, and bracelet design for enhanced usage, accuracy, and comfort for those unable to wear traditional pulse oximeters. The user interface includes built-in UI, external and portable UI, bedside monitoring, and connection to patient monitoring systems, via wired and/or wireless means. Further systems include those with both melanin bias reducing pulse oximetry and heart telemetry in the same device, via either a wired or wireless compact waterproof system to be used for continuous monitoring including blood oxygen saturation as a 5.sup.th vital sign. Systems also include fall detection, bed alarm, and location services.

The present invention relates to a device (100) for determining a vital sign of a subject by use of PPG. The device comprises a processing unit (110) configured to obtain multiple first detection signals derived from electromagnetic radiation (90) from multiple measurement spots (30) on a skin region (12) of the subject illuminated by one or more illumination spots (20), wherein the electromagnetic radiation (90) enters the skin region (12) at the one or more illumination spots (20) and exits the skin region (12) at the multiple measurement spots (30). The processing unit (110) further obtains 3D image information (130) of the skin region (12) which allows determining the actual spot distance (15) between the measurements spots (30) and an illumination spot (20), respectively. This information can be used to interpret the PPG signal more precisely as without having the 3D image information only a projected distance can be determined if the skin surface is tilted. Additionally, this allows averaging PPG signals derived from a homogenous skin area to improve PPG signal strength and reduce noise. A system (500) comprising such a device and a corresponding method are further described.

Systems, methods, and computer-readable media for providing a decision support solution to medical professionals to optimize medical care through data monitoring and feedback treatment are provided herein. In another embodiment, a computer-implemented method for modeling patient outcomes resulting from treatment in a specific medical area includes receiving patient-specific data associated with a patient, determining a plurality of possible patient states under which the patient can be categorized, a current patient state under which the patient can be categorized and determining probabilities of the patient transitioning from any of the possible patient states to every other possible patient state.

Systems and methods are disclosed for non-invasively measuring blood glucose levels in a biological sample based on spectral data. This includes utilizing at least one light source configured to strike a target area of a sample, utilizing at least one light filter positioned to receive light transmitted through the target area of the sample from the at least one light source, utilizing at least one light detector positioned to receive light from the at least one light source and filtered by the at least one light filter, and to generate an output signal, having a time dependent current, which is indicative of the power of light detected, receiving the output signal from the at least one light detector with a processor, calculating the attenuance attributable to blood with a ratio factor based on the received output signal, and determining a blood glucose level based on the calculated attenuance.

Systems and methods are disclosed for non-invasively measuring blood glucose levels in a biological sample based on spectral data. This includes utilizing at least one light source configured to strike a target area of a sample, utilizing at least one light filter positioned to receive light transmitted through the target area of the sample from the at least one light source, utilizing at least one light detector positioned to receive light from the at least one light source and filtered by the at least one light filter, and to generate an output signal, having a time dependent current, which is indicative of the power of light detected, receiving the output signal from the at least one light detector with a processor, calculating the attenuance attributable to blood with a ratio factor based on the received output signal, and determining a blood glucose level based on the calculated attenuance.